Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

MDxHealth SA ADR (MDXH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow MDxHealth ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.950 +0.280    +10.49%
13:18:36 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 32,627
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.710 - 2.950
Type:  Equity
Market:  United States
MDxHealth ADR 2.950 +0.280 +10.49%

MDxHealth SA ADR Company Profile

 
Get an in-depth profile of MDxHealth SA ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

255

Equity Type

ADR

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Contact Information

Address CAP Business Center Rue d’Abhooz 31
Zone Industrielle des Hauts-Sarts Herstal, 4040
Belgium
Phone 32 4 257 70 21
Fax -

Top Executives

Name Age Since Title
Koen Hoffman 54 2018 Independent Non-Executive Chairman
Michael K. McGarrity 59 2019 CEO & Executive Director
Regine Slagmulder 55 2020 Independent Non-Executive Director
Gerrit A. Meijer - - Member of Scientific Advisory Board
Jonathan I. Epstein - 2011 Member of Scientific Advisory Board
James G. Herman - - Member of Scientific Advisory Board
Jan Groen 62 2010 Advisor to the Board
Donnie M. Hardison 71 2021 Independent Non-Executive Director
Eric M. Wallen - 2011 Member of Scientific Advisory Board
Hilde Windels 57 2017 Independent Non-Executive Director
Godelieve Verplancke 64 2017 Independent Non-Executive Director
Eric Bednarski - 2020 Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MDXH Comments

Write your thoughts about MDxHealth SA ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email